Viewing Study NCT05648318


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-02-28 @ 9:10 PM
Study NCT ID: NCT05648318
Status: COMPLETED
Last Update Posted: 2022-12-13
First Post: 2022-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation in Low-risk Patients
Sponsor: Zhang Xiaofeng,MD
Organization:

Study Overview

Official Title: 1L Oral Lactulose is an Effective Regimen for Bowel Preparation in Low-risk Patients
Status: COMPLETED
Status Verified Date: 2022-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Adequate quality of bowel preparation(BP) is essential for colonoscopy. In recently, Kang suggested that for low-risk patients, single dose of 2L PEG is an effective regimen for bowel preparation.However, due to the poor palatability, there still more than 30% patients with 2L regimen experienced nausea or vomiting in our center.

Oral lactulose is a treatment for constipation. Several studies have compared the effectiveness between use PEG and lactulose for colonoscopy preparation in average-risk patients. However, the data in low-risk patients is vacant. The objective of current study was to compared the effectiveness of bowel preparation and patient tolerance using lactulose and 2L PEG regimen in low-risk patients.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: